This section catalogues every formal authority action — EMA, FDA, MHRA, Swissmedic, BfArM, CBG/MEB, ANSM and the other national medicines agencies of the EU-27 — that touches a peptide in our encyclopedia.
What we are building:
- A 27-jurisdiction grid showing per-country status for each compound (authorised, restricted, prohibited, unclassified).
- A chronological changelog of status changes, with the source document, effective date, and a one-paragraph editorial summary.
- Subscription-grade alerts when a status changes — free, plain-language, no commercial intent.
Where the data comes from
Our regulatory harvester polls EMA, FDA, MHRA, BfArM and the Lareb signal database daily, plus a rotating sample of the smaller EU agencies weekly. Every harvested item is fact-checked by our editorial team before it surfaces here — we do not auto-publish from a feed.
Timeline
The first country grid is shipping in Q3 2026, starting with the 14 compounds in our flagship encyclopedia coverage. The changelog is already running internally — you can see queue depth on the homepage ticker.